Dow Chemical 2011 Annual Report Download - page 194

Download and view the complete annual report

Please find page 194 of the 2011 Dow Chemical annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 272

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • 182
  • 183
  • 184
  • 185
  • 186
  • 187
  • 188
  • 189
  • 190
  • 191
  • 192
  • 193
  • 194
  • 195
  • 196
  • 197
  • 198
  • 199
  • 200
  • 201
  • 202
  • 203
  • 204
  • 205
  • 206
  • 207
  • 208
  • 209
  • 210
  • 211
  • 212
  • 213
  • 214
  • 215
  • 216
  • 217
  • 218
  • 219
  • 220
  • 221
  • 222
  • 223
  • 224
  • 225
  • 226
  • 227
  • 228
  • 229
  • 230
  • 231
  • 232
  • 233
  • 234
  • 235
  • 236
  • 237
  • 238
  • 239
  • 240
  • 241
  • 242
  • 243
  • 244
  • 245
  • 246
  • 247
  • 248
  • 249
  • 250
  • 251
  • 252
  • 253
  • 254
  • 255
  • 256
  • 257
  • 258
  • 259
  • 260
  • 261
  • 262
  • 263
  • 264
  • 265
  • 266
  • 267
  • 268
  • 269
  • 270
  • 271
  • 272

100
The following table summarizes the fair value of financial instruments at December 31, 2011 and 2010:
Fair Value of Financial Instruments at December 31
In millions
Marketable securities: (1)
Debt securities:
Government debt (2)
Corporate bonds
Total debt securities
Equity securities
Total marketable securities
Long-term debt including debt
due within one year (3)
Derivatives relating to:
Foreign currency
Commodities
2011
Cost
$ 556
652
$ 1,208
646
$ 1,854
$ (21,059)
$ —
$ —
Gain
$ 62
73
$ 135
57
$ 192
$ 6
$ 31
$ 16
Loss
$ —
(2)
$ (2)
(36)
$ (38)
$(2,736)
$ (17)
$ (1)
Fair
Value
$ 618
723
$ 1,341
667
$ 2,008
$(23,789)
$ 14
$ 15
2010
Cost
$ 603
760
$ 1,363
501
$ 1,864
$(22,360)
$ —
$ —
Gain
$ 40
72
$ 112
94
$ 206
$ 175
$ 40
$ 14
Loss
$ (2)
(1)
$ (3)
(3)
$ (6)
$(2,530)
$ (38)
$ (4)
Fair
Value
$ 641
831
$ 1,472
592
$ 2,064
$(24,715)
$ 2
$ 10
(1) Included in “Other investments” in the consolidated balance sheets.
(2) U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities’ obligations.
(3) Cost includes reductions of $23 million at December 31, 2011 and $23 million at December 31, 2010 related to fair value adjustments.
Risk Management
Dow’s business operations give rise to market risk exposure due to changes in interest rates, foreign currency exchange rates,
commodity prices and other market factors such as equity prices. To manage such risks effectively, the Company enters into
hedging transactions, pursuant to established guidelines and policies, which enable it to mitigate the adverse effects of financial
market risk. Derivatives used for this purpose are designated as cash flow, fair value or net foreign investment hedges where
appropriate. Accounting guidance requires companies to recognize all derivative instruments as either assets or liabilities at fair
value. A secondary objective is to add value by creating additional nonspecific exposures within established limits and policies;
derivatives used for this purpose are not designated as hedges. The potential impact of creating such additional exposures is not
material to the Company’s results.
The Company’s risk management program for interest rate, foreign currency and commodity risks is based on
fundamental, mathematical and technical models that take into account the implicit cost of hedging. Risks created by derivative
instruments and the mark-to-market valuations of positions are strictly monitored at all times, using value at risk and stress
tests. Counterparty credit risk arising from these contracts is not significant because the Company minimizes counterparty
concentration, deals primarily with major financial institutions of solid credit quality, and the majority of its hedging
transactions mature in less than three months. In addition, the Company minimizes concentrations of credit risk through its
global orientation by transacting with large, internationally diversified financial counterparties. It is the Company’s policy to
not have credit-risk-related contingent features in its derivative instruments. No significant concentration of counterparty credit
risk existed at December 31, 2011. The Company does not anticipate losses from credit risk, and the net cash requirements
arising from counterparty risk associated with risk management activities are not expected to be material in 2012.
The Company revises its strategies as market conditions dictate and management reviews its overall financial strategies
and the impacts from using derivatives in its risk management program with the Company’s Board of Directors.
Interest Rate Risk Management
The Company enters into various interest rate contracts with the objective of lowering funding costs or altering interest rate
exposures related to fixed and variable rate obligations. In these contracts, the Company agrees with other parties to exchange,
at specified intervals, the difference between fixed and floating interest amounts calculated on an agreed-upon notional
principal amount. At December 31, 2011, the Company had no open interest rate swaps.
Foreign Currency Risk Management
The Company’s global operations require active participation in foreign exchange markets. The Company enters into foreign
exchange forward contracts and options, and cross-currency swaps to hedge various currency exposures or create desired
exposures. Exposures primarily relate to assets, liabilities and bonds denominated in foreign currencies, as well as economic
exposure, which is derived from the risk that currency fluctuations could affect the dollar value of future cash flows related to
operating activities. The primary business objective of the activity is to optimize the U.S. dollar value of the Company’s assets,